Peer-reviewedCC BYFrontiers in pharmacology16 Oct 2026

Immune checkpoint inhibitors across neoadjuvant, perioperative, and adjuvant settings for resectable non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials

Jincan Dai¹
Mengni Liu²
Hu Li¹
Yao Wang³

¹Dali Bai Autonomous Prefecture People’s Hospital , , ,
²The Seventh Retired Cadres Rest Center of Jinan, Shandong Provincial Military Command , , ,
³Jinan Fifth People’s Hospital Affiliated to Shandong Second Medical University , , ,

Umbrella review of meta-analyses: perioperative immune checkpoint inhibitor therapy in resectable gastric and gastroesophageal junction adenocarcinoma
Michele Ghidini, Gloria Arena, Lorenzo Dottorini +4
Frontiers in Oncology5 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref
Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
Ifrah Mohamud Osman, Siyu Peng, Heshi Liu +3
BMC surgery29 Jul 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Efficacy and safety of apatinib-containing neoadjuvant regimens for resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and single-arm meta-analysis
Kaiyi Xin, Zhilu Chen, Liu Yang +4
Frontiers in Oncology19 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis
Ahmed Farid Gadelmawla, Ahmed A. Abo Elnaga, Abdullah Faisal Albukhari +10
Future Oncology19 Sep 2026Peer-reviewedLicence not statedFull textClinical trials & evidence synthesisPMC
The efficacy and safety of neoadjuvant chemotherapy plus immune check point inhibitors for locally advanced cervical cancer: a systematic review and meta-analysis.
Jianqing Xu, Jing Chen, Lin Zhu +1
BMC cancer1 Jul 2026Peer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMCDOAJ

Cite

BibTeX

@article{dai2026immune,
  title = {{Immune checkpoint inhibitors across neoadjuvant, perioperative, and adjuvant settings for resectable non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials}},
  author = {Jincan Dai and Mengni Liu and Hu Li and Yao Wang},
  journal = {Frontiers in pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13654980},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitors across neoadjuvant, perioperative, and adjuvant settings for resectable non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials
AU  - Jincan Dai
AU  - Mengni Liu
AU  - Hu Li
AU  - Yao Wang
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in pharmacology
UR  - https://europepmc.org/article/PMC/PMC13654980
SN  - 1663-9812
ER  -

Related

Cite